News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
16,101 Results
Type
Article (840)
Company Profile (19)
Press Release (15242)
Section
Business (5439)
Career Advice (22)
Deals (842)
Drug Delivery (2)
Drug Development (2898)
Employer Resources (2)
FDA (256)
Job Trends (397)
News (8992)
Policy (564)
Tag
Academia (56)
Adcomms (3)
Allergies (3)
Alliances (1378)
Alzheimer's disease (16)
Antibody-drug conjugate (ADC) (5)
Approvals (257)
Artificial intelligence (3)
Bankruptcy (4)
Best Places to Work (347)
BIOSECURE Act (4)
Biotechnology (15)
Cancer (44)
Cardiovascular disease (4)
Career advice (17)
CAR-T (10)
Cell therapy (23)
Clinical research (2243)
Collaboration (16)
Compensation (7)
COVID-19 (112)
CRISPR (4)
C-suite (7)
Data (42)
Diabetes (3)
Diagnostics (44)
Earnings (1749)
Events (2882)
Executive appointments (17)
FDA (274)
Funding (17)
Gene editing (8)
Gene therapy (16)
GLP-1 (21)
Government (63)
Healthcare (514)
Infectious disease (114)
Inflammatory bowel disease (6)
Intellectual property (3)
IPO (482)
Job creations (65)
Job search strategy (16)
Layoffs (9)
Legal (119)
Lung cancer (5)
Lymphoma (9)
Manufacturing (7)
Medical device (125)
Medtech (125)
Mergers & acquisitions (367)
Metabolic disorders (7)
Neuroscience (20)
NextGen Class of 2024 (184)
Non-profit (51)
Northern California (68)
Obesity (4)
Patents (7)
Patient recruitment (3)
People (1966)
Phase I (949)
Phase II (1061)
Phase III (680)
Pipeline (14)
Policy (6)
Postmarket research (39)
Preclinical (287)
Radiopharmaceuticals (4)
Rare diseases (6)
Real estate (153)
Regulatory (421)
Research institute (76)
Resumes & cover letters (5)
Series A (6)
Southern California (66)
Startups (119)
United States (478)
Vaccines (16)
Date
Last 7 days (20)
Last 30 days (72)
Last 365 days (1190)
2024 (1183)
2023 (1465)
2022 (1844)
2021 (1908)
2020 (1517)
2019 (1067)
2018 (788)
2017 (822)
2016 (701)
2015 (836)
2014 (528)
2013 (430)
2012 (375)
2011 (419)
2010 (400)
Location
Africa (17)
Asia (1330)
Australia (117)
California (180)
Canada (53)
China (20)
Connecticut (7)
Delaware (4)
Europe (1716)
Florida (12)
Illinois (6)
Maryland (42)
Massachusetts (85)
Minnesota (5)
New Jersey (42)
New York (17)
North Carolina (23)
Northern California (68)
Pennsylvania (31)
South America (15)
Southern California (66)
Texas (13)
Washington State (8)
16,101 Results for "eleven biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Eleven Therapeutics Welcomes Dr. Paloma H Giangrande as Chief Technology Officer
Eleven Therapeutics proudly announces the appointment of Dr. Paloma H Giangrande as the company’s Chief Technology Officer (CTO).
January 11, 2024
·
3 min read
Press Releases
Calidi Biotherapeutics Announces Proposed Public Offering
November 14, 2024
·
4 min read
Press Releases
Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference 2024
November 12, 2024
·
3 min read
Press Releases
FORE Biotherapeutics to Participate in Upcoming November Conferences
November 7, 2024
·
1 min read
Biotech Bay
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - September 22, 2023
Iovance Biotherapeutics, Inc. announced that on September 21, 2023, the Company approved the grant of inducement stock options covering an aggregate of 174,400 shares of Iovance’s common stock to eleven new non-executive employees.
September 22, 2023
·
5 min read
Press Releases
FORE Biotherapeutics to Participate in the Wells Fargo Virtual Private Biotech Symposium
December 5, 2024
·
1 min read
Press Releases
Capsida Biotherapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
December 19, 2024
·
1 min read
Press Releases
FORE Biotherapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 19, 2024
·
1 min read
Press Releases
Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference
November 14, 2024
·
1 min read
SAb Biotherapeutics Rebrands as SAB BIO
SAB Biotherapeutics today announced its new name, SAB BIO, and visual identity to more closely align with its mission to treat and prevent immune and autoimmune disorders with the use of its unique immunotherapy platform.
June 20, 2024
·
5 min read
1 of 1,611
Next
